Skip to main content

Advertisement

ADVERTISEMENT

Cardiovascular News

News
12/10/2019
Researchers found that a new tool accurately predicts six-month mortality for older adults hospitalized with acute myocardial infarction.
Researchers found that a new tool accurately predicts six-month mortality for older adults hospitalized with acute myocardial infarction.
Researchers found that a new...
12/10/2019
Annals of Long-Term Care
News
12/05/2019
“These data could be useful for physician–patient communication about primary prevention strategies,” researchers explained.
“These data could be useful for physician–patient communication about primary prevention strategies,” researchers explained.
“These data could be useful for...
12/05/2019
Pharmacy Learning Network
News
12/03/2019
Researchers found that patients with atrial fibrillation commonly use nonsteroidal anti-inflammatory drugs along with oral anticoagulants, a practice that increases their risk of bleeding.
Researchers found that patients with atrial fibrillation commonly use nonsteroidal anti-inflammatory drugs along with oral anticoagulants, a practice that increases their risk of bleeding.
Researchers found that patients...
12/03/2019
Pharmacy Learning Network

Advertisement

News
11/26/2019
Researchers recently assessed fracture risk among older adults taking warfarin compared to those taking direct oral anticoagulants, and found that warfarin was associated with increased risk of fractures.
Researchers recently assessed fracture risk among older adults taking warfarin compared to those taking direct oral anticoagulants, and found that warfarin was associated with increased risk of fractures.
Researchers recently assessed...
11/26/2019
Annals of Long-Term Care
News
11/14/2019
The American Heart Association and American College of Cardiology have released a report containing new clinical performance and quality measures for the diagnosis and treatment of hypertension in adults.
The American Heart Association and American College of Cardiology have released a report containing new clinical performance and quality measures for the diagnosis and treatment of hypertension in adults.
The American Heart Association...
11/14/2019
Pharmacy Learning Network
News
11/06/2019
Study findings show that 60% of patients receive inadequate care for major depressive disorder following heart attack or stroke, which researchers say is linked with notably higher health care costs.
Study findings show that 60% of patients receive inadequate care for major depressive disorder following heart attack or stroke, which researchers say is linked with notably higher health care costs.
Study findings show that 60% of...
11/06/2019
First Report Managed Care

Advertisement

News
10/28/2019
In a recent study, researchers compared effectiveness and safety of antihypertensive drugs and outcomes from observational data from 4.9 million patients.
In a recent study, researchers compared effectiveness and safety of antihypertensive drugs and outcomes from observational data from 4.9 million patients.
In a recent study, researchers...
10/28/2019
Pharmacy Learning Network
News
10/28/2019
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people living with HIV] may be at a substantial disadvantage in terms of receiving correct statin therapy for ASCVD risk reduction,” the researchers concluded.
“This study reveals that [people...
10/28/2019
Pharmacy Learning Network
News
10/25/2019
According to study findings, higher blood pressure variability is associated with greater cognitive and functional deterioration in Alzheimer disease.
According to study findings, higher blood pressure variability is associated with greater cognitive and functional deterioration in Alzheimer disease.
According to study findings,...
10/25/2019
Annals of Long-Term Care

Advertisement

News
10/24/2019
Beginning next year, the official list price for the cholesterol drug Repatha (evolocumab) will be the lower price Amgen began offering last year to patients on Medicare and those paying for the drug out-of-pocket.
Beginning next year, the official list price for the cholesterol drug Repatha (evolocumab) will be the lower price Amgen began offering last year to patients on Medicare and those paying for the drug out-of-pocket.
Beginning next year, the...
10/24/2019
First Report Managed Care

Advertisement